Casa bronstein méier resultado

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year

Por um escritor misterioso

Last updated 19 abril 2025

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year

Diagnosis and management of acute ischaemic stroke

Thrombolytic Therapy in Stroke: Ischemic Stroke and Neurologic Deficits, Clinical Trials, Thrombolysis Guidelines

Acute Ischemic Stroke and Long-Term Outcome After Thrombolysis

Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke

Use of tPA for the Management of Acute Ischemic Stroke in the ED: ACEP Policy

– Emergency Medicine EducationThrombolytic Use for STEMI: What ED Clinicians Should Know - - Emergency Medicine Education

IJERPH, Free Full-Text

Frontiers Factors associated with functional disability in patients with acute stroke excluded from alteplase administration due to minor non-disabling neurological deficits

Full article: Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplase

Tissue Plasminogen Activator for Acute Ischemic Stroke (Alteplase, Activase®)

The Neurotoxicity of Tissue Plasminogen Activator? - Jaspreet Kaur, Zonghang Zhao, Gary M. Klein, Eng H. Lo, Alastair M. Buchan, 2004

Recomendado para você